Oncology Institute Inc
The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as education… Read more
Oncology Institute Inc (TOI) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 1.029x
Based on the latest financial reports, Oncology Institute Inc (TOI) has a cash flow conversion efficiency ratio of 1.029x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-12.63 Million) by net assets ($-12.27 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Oncology Institute Inc - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how Oncology Institute Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Oncology Institute Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Oncology Institute Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Liaoning Fu-An
SHG:603315
|
0.070x |
|
Hangzhou Weiguang Electronic Co Ltd
SHE:002801
|
0.018x |
|
Tanla Platforms Limited
NSE:TANLA
|
0.074x |
|
Jiangsu Holly Corp
SHG:600128
|
0.038x |
|
Village Farms International Inc
NASDAQ:VFF
|
0.084x |
|
Matrix Service Co
NASDAQ:MTRX
|
0.054x |
|
Sichuan Goldstone Orient New Material Equipment Co Ltd
SHE:300434
|
0.063x |
|
Jw Pharmac
KO:001060
|
0.132x |
Annual Cash Flow Conversion Efficiency for Oncology Institute Inc (2019–2024)
The table below shows the annual cash flow conversion efficiency of Oncology Institute Inc from 2019 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $3.59 Million | $-26.54 Million | -7.394x | -1061.11% |
| 2023-12-31 | $57.02 Million | $-36.31 Million | -0.637x | -27.02% |
| 2022-12-31 | $123.17 Million | $-61.76 Million | -0.501x | -59.80% |
| 2021-12-31 | $104.16 Million | $-32.68 Million | -0.314x | -1835.57% |
| 2020-12-31 | $28.10 Million | $508.00K | 0.018x | -78.89% |
| 2019-12-31 | $42.22 Million | $3.62 Million | 0.086x | -- |